ArticlePloS one2021

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge.

Lisa M Frenkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.